-
Mashup Score: 3GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse - 11 day(s) ago
Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).
Source: www.gov.ukCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 22
BackgroundCardiac rehabilitation (CR) is a multicomponent intervention to reduce adverse outcomes from coronary artery disease, but its mechanisms are not fully understood. The aims of this study w…
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 10Wes Streeting wants to hand obese patients drug - 22 day(s) ago
The health secretary believes the latest generation of weight-loss medicine could have a ‘monumental’ impact on obesity in the UK and ease the financial burden on the NHS and the economy.
Source: www.dailymail.co.ukCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 16Nobel Prize goes to microRNA researchers - 29 day(s) ago
US scientists Victor Ambros and Gary Ruvkun helped explain how genes work inside the human body.
Source: www.bbc.co.ukCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 10Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia | NEJM - 29 day(s) ago
Persons with mixed hyperlipidemia are at risk for atherosclerotic cardiovascular disease due to an elevated non–high-density lipoprotein (HDL) cholesterol level, which is driven by remnant choleste…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 16Combination lipid-lowering therapy as first-line strategy in very high-risk patients - 1 month(s) ago
When diet and lifestyle are insufficient to attenuate the risk of atherosclerotic cardiovascular disease, pharmacotherapy is mandated. A global approach th
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 13
Esperion is dedicated to discovering, developing and commercializing innovative and combination medicines to reduce cardiovascular risk.
Source: www.esperion.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 6
Help us transform lives at our Sandwell and West Birmingham hospitals and community healthcare services. To support us, please visit https://www.justgiving.c…
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 5XXXII Congresso Português de Aterosclerose - 1 month(s) ago
Boas-vindas A aterosclerose, a dislipidemia e a doença cardiovascular são temas transversais na sociedade científica e na sociedade em geral, havendo todos os anos necessidade de atualização, com inovações quer a nível diagnóstico quer a nível terapêutico. Há sempre evidência científica a descobrir e a conhecer, há sempre uma enorme motivação em discutir interpares todas as atualizações que vão surgindo e a forma como as aplicar na nossa prática clínica. Existe também a noção que há ainda muito para
Source: www.cpa2024.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Revolutionizing Brain Health: Genetics, Lipid Science, and Cutting-Edge Dementia Prevention - 1 month(s) ago
What does cholesterol have to do with dementia? Join me in Episode #333 as I sit down with Dr Kellyann Niotis and Dr Thomas Dayspring to explore how choleste…
Source: www.youtube.comCategories: General Medicine News, Cardiologists1Tweet
I love the understatement of the UK government in their latest advice re GLP-1s “be aware there have been “reports”of potential misuse of GLP-1RAs for unauthorised indications such as aesthetic weight loss” Presumably “reports” in @DailyMailCeleb https://t.co/JcAj7o2BEA